FDA authorizes new drug to protect immune compromised from Covid-19 - STAT News

Retrieved on: 2024-03-23 11:04:02

Tags for this article:

COVID-19 pandemic in Botswana

COVID-19 pandemic in South Africa

SARS-CoV-2 Omicron variant

Immunodeficiency

COVID-19

Antibody

Organ transplantation

Pfizer-BioNTech COVID-19 vaccine

AstraZeneca

Click the tags to see associated articles and topics

FDA authorizes new drug to protect immune compromised from Covid-19 - STAT News. View article details on HISWAI: https://www.statnews.com/2024/03/22/covid-immunocompromised-antibody-protection-invivyd/

Summary

The FDA authorized a new antibody drug, Pemgarda by Invivyd, for immunocompromised individuals, offering protection against COVID-19 variants like Omicron, following the ineffectiveness of AstraZeneca's Evusheld.

Article found on: www.statnews.com

View Original Article